Guide PCI Planning and Treatment Decisions With Abbott's Intravascular Imaging Portfolio

Optical Coherence Tomography (OCT) is Abbott's intravascular imaging modality used during PCI to guide treatment decisions.

OCT provides automated, accurate measurements to help guide stent selection, placement and deployment.¹ OCT reduces ambiguities impacting vessel prep, stent sizing and expansion to deliver optimal results.²

Intravascular imaging with OCT is performed using Ultreon™ 1.0 Software, Dragonfly™ Imaging Catheters, and the OPTIS™ Imaging Systems.

References

1. Reyes, M. The next innovation in PCI is not a stent. The value of OCT. CathLab Digest. Oct 6, 2019. Volume 27, Issue 10.
2. Bezerra, H. et al: Analysis of changes in decision-making process during OCT-guided PCI - Insights from the LightLab Initiative. EuroPCT2020 Presentation.
3. Data on file at Abbott.
4. Zhang J, et al. Intravasculard ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126-3137. doi: 10.1016/j.jacc.2018.09.013.
5. Hong M, et al. IVUS-XPL 5 Year Outcomes, TCT 2019.
6. Jones et al. JACC Cardiovascular Interventions, 2018, vol 11 (14). Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention — Outcomes From the Pan-London PCI Cohort.